Diethyl 1‐(4‐fluoro­phenyl)‐3‐(2‐furyl)‐5‐oxopyrrolidine‐2,2‐di­carboxyl­ate and diethyl 1‐(3,4‐di­chloro­phenyl)‐3‐(2‐furyl)‐5‐oxopyrrolidine‐2,2‐di­carboxyl­ate

The title compounds, C₂₀H₂₀FNO₆ and C₂₀H₁₉Cl₂NO₆, respectively, may exhibit bioactivity. In these compounds, the pyrrolidine ring adopts a conformation intermediate between envelope and half‐chair. Only one of the two ethoxy­carbonyl side chains is nearly planar. Centrosymmetric pairs are formed, and the crystal structure is stabilized by weak C—H?O hydrogen bonds and van der Waals interactions.